Literature DB >> 27174045

Prucalopride: For functional constipation only?

M Bellini1, D Gambaccini1, G Bassotti2.   

Abstract

Prucalopride is a new prokinetic agent, recently available in Europe for the treatment of functional constipation in adults in whom treatment with laxatives failed to provide adequate relief. However, due to its intrinsic properties (highly selective agonist activity and high affinity for 5-HT4 receptors, neuroprotection), this drug has shown the potential to be used in other pathologic conditions, in and outside of the gastrointestinal tract. We performed a systematic review of the evidence supporting these possible alternative uses of prucalopride. Further studies in this area are, however, mandatory.

Entities:  

Keywords:  Alternative uses; Constipation; Prucalopride; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27174045     DOI: 10.1007/s10151-016-1477-8

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  27 in total

1.  Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice.

Authors:  M Cachard-Chastel; S Devers; S Sicsic; M Langlois; F Lezoualc'h; A M Gardier; C Belzung
Journal:  Behav Brain Res       Date:  2007-10-18       Impact factor: 3.332

Review 2.  Serotonin and neuroprotection in functional bowel disorders.

Authors:  M D Gershon; M-T Liu
Journal:  Neurogastroenterol Motil       Date:  2007-08       Impact factor: 3.598

3.  5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study.

Authors:  N H Prins; A van Der Grijn; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

4.  Role of prucalopride in treatment of chronic constipation and recurrent functional obstruction in a patient with steinert myotonic dystrophy.

Authors:  Mariano Cesare Giglio; Gaetano Luglio; Rachele Tarquini; Domenico Cerbone; Paolo Bucci; Luigi Bucci
Journal:  J Clin Gastroenterol       Date:  2015-01       Impact factor: 3.062

5.  Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.

Authors:  K Krogh; M Bach Jensen; P Gandrup; S Laurberg; J Nilsson; R Kerstens; M De Pauw
Journal:  Scand J Gastroenterol       Date:  2002-04       Impact factor: 2.423

6.  Prucalopride exerts neuroprotection in human enteric neurons.

Authors:  Francesca Bianco; Elena Bonora; Dipa Natarajan; Manuela Vargiolu; Nikhil Thapar; Francesco Torresan; Fiorella Giancola; Elisa Boschetti; Umberto Volta; Franco Bazzoli; Maurizio Mazzoni; Marco Seri; Paolo Clavenzani; Vincenzo Stanghellini; Catia Sternini; Roberto De Giorgio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-18       Impact factor: 4.052

7.  Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats.

Authors:  B Y De Winter; G E Boeckxstaens; J G De Man; T G Moreels; J A Schuurkes; T L Peeters; A G Herman; P A Pelckmans
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

8.  Randomised clinical trial: prucalopride, a colonic pro-motility agent, reduces the duration of post-operative ileus after elective gastrointestinal surgery.

Authors:  J Gong; Z Xie; T Zhang; L Gu; W Yao; Z Guo; Y Li; N Lu; W Zhu; N Li; J Li
Journal:  Aliment Pharmacol Ther       Date:  2016-02-15       Impact factor: 8.171

9.  Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study.

Authors:  A V Emmanuel; M A Kamm; A J Roy; R Kerstens; L Vandeplassche
Journal:  Aliment Pharmacol Ther       Date:  2011-11-08       Impact factor: 8.171

10.  Prucalopride reduces the number of reflux episodes and improves subjective symptoms in gastroesophageal reflux disease: a case series.

Authors:  Simon Nennstiel; Monther Bajbouj; Roland M Schmid; Valentin Becker
Journal:  J Med Case Rep       Date:  2014-02-05
View more
  1 in total

1.  Effects of Single-Dose Prucalopride on Intestinal Hypomotility in Horses: Preliminary Observations.

Authors:  Fulvio Laus; Margherita Fratini; Emanuele Paggi; Vanessa Faillace; Andrea Spaterna; Beniamino Tesei; Katia Fettucciari; Gabrio Bassotti
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.